The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 HiTech Pharmacal Co. Inc.  (HITK) Trade Now »     Rate HITK  -  Discuss HITK  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
33.0%
Top:
0.0%
Rate HITK:



HITK Analysis & Videos »


HITK: Bull or Bear?

look for HITK to double in value......trailing PE is no longer relevant Graphic_rating_buy HITK
N/A
 -2.23%
in 54 days
<> <> I am a CPA veteran and stock analysis enthusiast that has been actively researching and following HITK for a long time.  Sales, margins, and net profits for the company are growing off the charts over the past 6 months. They appear to have quietly arrived in the generic drug industry as a competitor on a new level. The company's trailing PE of 15 includes $1.5M earnings for the 2nd and 3rd qtrs of the prior fiscal year........but these amounts don't appear very relevant considering consecutive record breaking quarters of $5M and $8M earnings for the more recent 4th qtr of last year and t<><><><><><><><><><><><><><>...
By  toddschaus   (-2.23%  risk: conservative)  09/16/09 Comment


New Indexes to Track Healthcare Trends and More Graphic_rating_buy HITK
Mikerun
73%
 +32.94%
in 97 days

Below are links and descriptions for 23 new stock indexes I have created, revised, and tracked over the past few years which are now featured at a new website called Investars YOU. The new site includes automated index tracking, allows investors to create custom stock portfolios based on their individual preferences, and now features free access to all of the component stocks in each of my indexes. Some of the top performing stocks from my healthcare indexes on a year-to-date basis are highlighted below.

Cosmetic & Restorative Medicine Index: Allergan (NYSE:AGN) (+38%)

<> The <> ...
By  Mike Havrilla   (+1.04%  risk: conservative)  08/04/09 Comment


Big Pharma Goes Generic Graphic_rating_buy HITK
Mikerun
73%
 +185.34%
in 159 days
(closed on 08/04/09)
Big Pharma Goes Generic edit
<> <> <> <> <> <> Sanofi-Aventis (SNY) is now the 11 th largest generic drug maker in the world following its successful acquisition of Czech generic drug company Zentiva. As $70B in brand drug patents are set to expire through 2012, big pharma companies are hedging their bets through generic drug divisions, including Pfizer (PFE) - Greenstone, Novartis (NVS) - Sandoz, and the recently announced Merck (MRK) BioVent...
By  Mike Havrilla   (+1.04%  risk: conservative)  02/26/09 Comment


Get free stock alert for HITK:
Your Email Address:


Hi-Tech Pharmacal: Hi-Growth at a Value Price Graphic_rating_buy HITK
Mikerun
73%
 +13.19%
in 29 days
(closed on 02/26/09)
Hi-Tech Pharmacal: Hi-Growth at a Value Price
 
With shares of Home Diagnostics (HDIX) surging by nearly 50% since I profiled the company in mid-December as a turnaround, value play from the ETF Innovators Healthcare Cost Containment Index ; a search for compelling values among these companies today led me to generic drug maker Hi-Tech Pharmacal (HITK).
 
<> Shares of HITK are down by about 10% in the past five days on light volume and no news headlines, providing a nice chance to accumulate some shares. The Company reported record quarterly revenue for i...
By  Mike Havrilla   (+1.04%  risk: conservative)  01/28/09 Comment


Healthcare Hot Spots Beyond Stem Cells Graphic_rating_buy HITK
Mikerun
73%
 +0.21%
in 2 days
(closed on 01/28/09)
Beyond Stem Cells: Healthcare Hot Spots
 
With the surprise announcement last week by Geron (GERN) that the FDA would allow human clinical trials for embryonic stem cells, all companies in the underlying ETF Innovators Index to track the space are screaming higher again today – led by the company with the biggest gains over the past year, StemCells (STEM).
 
 
<> Below are three additional areas and associated companies for investors to consider in the search of the next hot s...
By  Mike Havrilla   (+1.04%  risk: conservative)  01/26/09 Comment


Tender Offer for Taro Pharma Tarries Along Graphic_rating_buy HITK
Mikerun
73%
 -25.50%
in 46 days
(closed on 01/26/09)

Tender Offer for Taro Pharma Tarries Along

<>

India's largest generic drug company [ web link to analysis of this market ] by market cap, Sun Pharma (Bombay: 524715), and Israel-based Taro Pharma (TAROF) have one month to reach agreement on an outstanding tender offer of $7.75 per share by Sun Pharma to acquire its smaller rival or the Israel Supreme Court will decide on the case. In early 2007, Taro agreed to the deal as it was struggling to survive and Sun invested $60M as part of a private placement to resolve Taro's liquidity issues.

However, in May ...
By  Mike Havrilla   (+1.04%  risk: conservative)  12/10/08 Comment


Look for Laggards after Latest Rally Graphic_rating_buy HITK
Mikerun
73%
 -7.02%
in 1 day
(closed on 12/10/08)

Look For Laggards After Latest Market Rally

<>

With the S&P 500 SPDR (SPY) trading to the upside by more than 10% in the last five days on the prospects for a short-term $15B rescue package for U.S. auto makers to prevent rising unemployment rates from skyrocketing into double digits, Caraco Pharma (CPD) and Altria Group (MO) represent two laggards from defensive industry groups.

The accompanying one-month chart [click to enlarge] illustrates a highly correlated sell-off in Caraco and another small generic drug company, Hi-Tech Pharmacal (HITK), with H...
By  Mike Havrilla   (+1.04%  risk: conservative)  12/09/08 Comment


Generic Cardio Drugs Equal Brands - JAMA Graphic_rating_buy HITK
Mikerun
73%
 +77.23%
in 7 days
(closed on 12/09/08)

Generic Cardio Drugs Equal Brands - JAMA

<>

A meta-analysis review of clinical studies published in peer-reviewed journals was featured today in The Journal of the American Medical Association [JAMA] and concluded that cost-saving generics used to treat a variety of cardiovascular conditions produced equivalent clinical outcomes to higher cost brand name drugs. Despite this clinical evidence, the review notes that a majority (53%) of the 43 editorials analyzed had a negative opinion on generic substitution.

While there are currently no ETFs on the market w...
By  Mike Havrilla   (+1.04%  risk: conservative)  12/02/08 Comment


Get free stock alert for HITK:
Your Email Address:


A New Index of Healthcare Cost Containment Companies Graphic_rating_buy HITK
Mikerun
73%
 -28.60%
in 12 days
(closed on 12/02/08)

A New Index of Healthcare Cost Containment Companies

<>
<> The ETF Innovators [ETFI] Global Healthcare Cost Containment Index profiled in the accompanying table includes companies with market caps over $250M which are involved in the following two segments of the healthcare sector with the common theme of reducing healthcare costs and insurance premiums for consumers, employers, and third-party payers such as the government (through Medicare recipients) and insurance companies.

Generic Healthcare Products: This category includes generic prescription a...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/20/08 1 comment


10 Under the Radar Small & Micro-Cap Value Stocks Graphic_rating_buy HITK
Mikerun
73%
 -3.43%
in 5 days
(closed on 11/20/08)

10 Under the Radar Small & Micro-Cap Value Stocks (Healthcare)

<>

The accompanying table presents 10 small and micro-cap companies from a variety of industries which are trading at value parameters, with average valuations for the group of 0.54X trailing 12-month sales, 0.44X enterprise value to sales, 0.88X book value, and 8.7X trailing 12-month earnings. The iShares Russell 2000 Small-Cap Value ETF (IWN) has lost about 39% in the past year and serves as a useful ETF benchmark comparison for these companies.

Healthcare – Diagnostics: Home Diagnostics (HDI< />< /><>< />< /><>...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/15/08 Comment


A Bullish Outlook for Generic Drugs After Election Graphic_rating_buy HITK
Mikerun
73%
 -20.86%
in 11 days
(closed on 11/15/08)

A Bullish Outlook for Generic Drugs After Election

<>

In addition to the favorable underlying trends I wrote about previously for the generic drug industry, both presidential candidates are bullish on the industry with the following excerpts taken directly from their websites:

Senator Obama : Lower drug costs by allowing the importation of safe medicines from other developed countries, increasing the use of generic drugs in public programs and taking on drug companies that block cheaper generic medicines from the market.

Senator McCain : R...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/04/08 Comment





People Bullish on HITK

toddschaus
Analyst
N/A
about 1 mo ago

Mikerun
Mike Havrilla
Principal
73%
3 mos ago


People Bearish on HITK

Crispy
crispy
Sr. Associate
74%
over 3 years ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +35.25% 368
2 Gerald Greene 18.14 +70.90% 206
3 stockmarketfunding.com 17.66 +25.78% 53
4 akiralegrand 13.47 +14.32% 60
5 anup2104 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment
DELL Dell Inc
GM General Motors Corp
INTC Intel Corp
T AT&T Inc
XOM Exxon Mobil Corp
C Citigroup Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on HITK


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About HiTech Pharmacal Co. Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch